ALR Technologies (QB) Stock Price

-0.002 (-3.51%)
Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
ALR Technologies Inc (QB) ALRT OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.002 -3.51% 0.055 11:41:20
Open Price Low Price High Price Close Price Prev Close
0.059 0.055 0.059 0.057
Bid Price Ask Price Spread News
0.055 0.059 0.004 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
8 43,843 $ 0.057767 $ 2,533 - 0.0199 - 0.087
Last Trade Time Type Quantity Stock Price Currency
11:41:20 7,192 $ 0.055 USD

ALR Technologies (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 28.11M 511.02M 92.11M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
1.18k $ - 0.00% - -

more financials information »

ALR Technologies (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ALRT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.0540.06250.05250.0567293222,5970.0011.85%
1 Month0.0680.0690.0450.0544567102,494-0.013-19.12%
3 Months0.0650.080.0450.0652607111,778-0.01-15.38%
6 Months0.0460.0870.0380.0631803117,2000.00919.57%
1 Year0.01990.0870.01990.0540772117,4740.0351176.38%
3 Years0.040.0870.00740.0474506124,7550.01537.5%
5 Years0.0050.14790.00060.0666815288,3990.051,000.0%

ALR Technologies (QB) Description

ALR Technologies is a medical device company that developed the ALRT Diabetes Solution, a comprehensive approach to diabetes care that includes: an FDA-cleared and HIPAA compliant diabetes management system that collects data directly from blood glucose meters and continuous glucose monitoring devices; a patent pending Predictive A1C algorithm to track treatment success between lab reports and an FDA-cleared Insulin Dosing Adjustment program. ALRT also offers an algorithm to provide prescribers support for timely non-insulin medication advancements. The overall goal is to optimize diabetes drug therapies to drive improved patient outcomes. The program tracks performance of all clinical activities to ensure best practices are followed. The ALRT Diabetes Solution gives providers a platform for remote diabetes care, helping to minimize patient exposure to potential infections in clinical settings. Currently, the Company is focused on diabetes and will expand its services to cover other chronic diseases anchored on verifiable data.

Your Recent History
ALR Techno..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.